FDA Approved: TUDORZA PRESSAIR — Original Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved Tudorza Pressair (aclidinium bromide) through an Original Application (NDA) submitted by Covis Pharma US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)

Snippet

ORIG AP for TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)